125 related articles for article (PubMed ID: 2846525)
61. Transcriptional and posttranscriptional regulation of type 1 plasminogen activator inhibitor and tissue-type plasminogen activator gene expression in HTC rat hepatoma cells by glucocorticoids and cyclic nucleotides.
Heaton JH; Kathju S; Gelehrter TD
Mol Endocrinol; 1992 Jan; 6(1):53-60. PubMed ID: 1738371
[TBL] [Abstract][Full Text] [Related]
62. Direct effects of gemfibrozil on the fibrinolytic system. Diminution of synthesis of plasminogen activator inhibitor type 1.
Fujii S; Sobel BE
Circulation; 1992 May; 85(5):1888-93. PubMed ID: 1572044
[TBL] [Abstract][Full Text] [Related]
63. Modulation of epidermal growth factor receptor gene expression by transforming growth factor-beta in a human breast carcinoma cell line.
Fernandez-Pol JA; Klos DJ; Hamilton PD; Talkad VD
Cancer Res; 1987 Aug; 47(16):4260-5. PubMed ID: 3496959
[TBL] [Abstract][Full Text] [Related]
64. Prolactin regulation of tissue type plasminogen activator and plasminogen activator inhibitor type-I gene expression in eCG-primed rat granulosa cells in culture.
Liu YX; Peng XR; Liu HZ; Chen YJ; Ny T
Biol Reprod; 1998 Aug; 59(2):409-16. PubMed ID: 9687315
[TBL] [Abstract][Full Text] [Related]
65. Plasminogen activator inhibitor-1 regulates macrophage-dependent postoperative adhesion by enhancing EGF-HER1 signaling in mice.
Honjo K; Munakata S; Tashiro Y; Salama Y; Shimazu H; Eiamboonsert S; Dhahri D; Ichimura A; Dan T; Miyata T; Takeda K; Sakamoto K; Hattori K; Heissig B
FASEB J; 2017 Jun; 31(6):2625-2637. PubMed ID: 28270519
[TBL] [Abstract][Full Text] [Related]
66. Dexamethasone inhibition of tissue-type plasminogen activator (tPA) activity: paradoxical induction of both tPA antigen and plasminogen activator inhibitor.
Gelehrter TD; Sznycer-Laszuk R; Zeheb R; Cwikel BJ
Mol Endocrinol; 1987 Jan; 1(1):97-101. PubMed ID: 3137452
[TBL] [Abstract][Full Text] [Related]
67. Compound Astragalus and Salvia miltiorrhiza extract suppresses hepatocellular carcinoma progression by inhibiting fibrosis and PAI-1 mRNA transcription.
Rui W; Xie L; Liu X; He S; Wu C; Zhang X; Zhang L; Yang Y
J Ethnopharmacol; 2014; 151(1):198-209. PubMed ID: 24247078
[TBL] [Abstract][Full Text] [Related]
68. Impact of statins on modulation by insulin of expression of plasminogen activator inhibitor type-1.
Sato Y; Dong J; Imagawa S; Ishimori N; Furumoto T; Tsutsui H; Sobel BE; Fujii S
Coron Artery Dis; 2008 Aug; 19(5):355-61. PubMed ID: 18607173
[TBL] [Abstract][Full Text] [Related]
69. Thrombin induction of plasminogen activator inhibitor mRNA in human umbilical vein endothelial cells in culture.
Heaton JH; Dame MK; Gelehrter TD
J Lab Clin Med; 1992 Aug; 120(2):222-8. PubMed ID: 1500822
[TBL] [Abstract][Full Text] [Related]
70. Interleukin-1 induction of type-1 plasminogen activator inhibitor (PAI-1) gene expression in the mouse hepatocyte line, AML 12.
Seki T; Gelehrter TD
J Cell Physiol; 1996 Sep; 168(3):648-56. PubMed ID: 8816919
[TBL] [Abstract][Full Text] [Related]
71. Plasminogen activator inhibitor 1: biosynthesis and mRNA level are increased by insulin in cultured human hepatocytes.
Kooistra T; Bosma PJ; Töns HA; van den Berg AP; Meyer P; Princen HM
Thromb Haemost; 1989 Sep; 62(2):723-8. PubMed ID: 2683191
[TBL] [Abstract][Full Text] [Related]
72. Epidermal plasminogen activator inhibitor (PAI) is immunologically identical to placental-type PAI-2.
Hibino T; Izaki S; Ohkuma M; Kon S; Thorsen S; Astedt B
FEBS Lett; 1988 Apr; 231(1):202-6. PubMed ID: 3129308
[TBL] [Abstract][Full Text] [Related]
73. The regulatory region of the human plasminogen activator inhibitor type-1 (PAI-1) gene.
Riccio A; Lund LR; Sartorio R; Lania A; Andreasen PA; Danø K; Blasi F
Nucleic Acids Res; 1988 Apr; 16(7):2805-24. PubMed ID: 3130610
[TBL] [Abstract][Full Text] [Related]
74. Angiotensin II stimulation of plasminogen activator inhibitor-1 gene expression in astroglial cells from the brain.
Rydzewski B; Zelezna B; Tang W; Sumners C; Raizada MK
Endocrinology; 1992 Mar; 130(3):1255-62. PubMed ID: 1537291
[TBL] [Abstract][Full Text] [Related]
75. Augmentation of synthesis of plasminogen activator inhibitor type 1 by insulin and insulin-like growth factor type I: implications for vascular disease in hyperinsulinemic states.
Schneider DJ; Sobel BE
Proc Natl Acad Sci U S A; 1991 Nov; 88(22):9959-63. PubMed ID: 1719559
[TBL] [Abstract][Full Text] [Related]
76. Concomitant secretion by A431 cells of tissue plasminogen activator and a specific inhibitor masks EGF modulation of tPA activity.
George F; Pourreau-Schneider N; Arnoux D; Boutière B; Berthois Y; Martin PM; Sampol J
Thromb Haemost; 1990 Nov; 64(3):407-11. PubMed ID: 2128970
[TBL] [Abstract][Full Text] [Related]
77. Production of plasminogen activators (PAs) in bovine cumulus-oocyte complexes during maturation in vitro: effects of epidermal growth factor on production of PAs in oocytes and cumulus cells.
Park KW; Choi SH; Song XX; Funahashi H; Niwa K
Biol Reprod; 1999 Jul; 61(1):298-304. PubMed ID: 10377062
[TBL] [Abstract][Full Text] [Related]
78. PAI-1 secretion and matrix deposition in human peritoneal mesothelial cell cultures: transcriptional regulation by TGF-beta 1.
Rougier JP; Guia S; Hagège J; Nguyen G; Ronco PM
Kidney Int; 1998 Jul; 54(1):87-98. PubMed ID: 9648067
[TBL] [Abstract][Full Text] [Related]
79. Role of protein kinase C and cyclic adenosine monophosphate in the regulation of tissue-type plasminogen activator, plasminogen activator inhibitor-1, and platelet-derived growth factor mRNA levels in human endothelial cells. Possible involvement of proto-oncogenes c-jun and c-fos.
Kooistra T; Bosma PJ; Toet K; Cohen LH; Griffioen M; van den Berg E; le Clercq L; van Hinsbergh VW
Arterioscler Thromb; 1991; 11(4):1042-52. PubMed ID: 1648385
[TBL] [Abstract][Full Text] [Related]
80. The THP-1 cell line is a urokinase-secreting mononuclear phagocyte with a novel defect in the production of plasminogen activator inhibitor-2.
Gross TJ; Sitrin RG
J Immunol; 1990 Mar; 144(5):1873-9. PubMed ID: 2307845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
